Stay updated with breaking news from Exscientia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exscientia (Nasdaq: EXAI) today announced that Company management will participate in the following investor conferences in September: Morgan Stanley Annual Global Healthcare Conference: Date:
Exscientia plc (Nasdaq: EXAI) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220817005681/en/ Recent developments in the Company's pipeline
Company to host conference call and webcast on August 18, 2022 at 1:30 p.m. BST 8:30 a.m. ET Exscientia (Nasdaq: EXAI), an AI-driven pharmatech company committed to discovering, designing and developing
The 20th to meet with me. so i'll let you know just how i feel about what a rascal you really are. you are a rude, thoughtless little pig. >> okay, wow. father of the year. don't forget baldwin. remember, he wanted to be a talk show host. it didn't work out well as planned. take a look. when can we take some calls on everyone? do we have calls on there? no calls yet. no calls yet. what number do people call to get on the air? i mean, do we have that number? it's right there. you know, do i have a call number in. oh, i'm so sorry. that's interesting. interesting. we have any calls yet? there ar...
The conference highlights the convergence of digital health and drug development. Among the panel discussions are a focus on the state of AI in drug discovery and the future of digital medicines. A startup pitch contest spotlights companies seeking to improve clinical trials. Register for free today!